XWELL, Inc. (XWEL) investor relations documents from the company's IR site: 2 presentations, 8 press releases; latest deck 2021-08-25. Read in-app with summaries. First-party data.
Presentation — XpresCheck COVID testing generated $10M/month in patient fees by Aug 2021, using airport locations. Potential for biosurveillance and employee monitoring exists.
| Published | Type | Document |
|---|---|---|
| 2026-08-05 | Press release | Press release |
| 2026-08-05 | Press release | XWELL Appoints Global Energy and Capital Markets Leader Gerard Reid to its Board of Directors |
| 2026-07-07 | Press release | Press release |
| 2026-07-07 | Press release | XWELL Announces Definitive Agreement to Divest XpresSpa and XpresTest Businesses |
| 2026-04-01 | Press release | XWELL Reports Fiscal 2025 Results |
| 2026-02-24 | Press release | XWELL Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules |
| 2026-02-03 | Press release | XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone |
| 2026-01-08 | Press release | XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor |
| 2021-08-25 | Presentation | Presentation |
| Presentation | Leveraging its Position as the Only Airport-Based National Health and Wellness Provider in COVID Times |
XWEL overview · XWEL earnings · XWEL financials · XWEL KPIs · XWEL ownership · XWEL peers · XWEL filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.